UK markets close in 6 hours 42 minutes

Bristol-Myers Squibb Company (0R1F.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
72.70+0.20 (+0.28%)
As of 07:03PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-19.22%
S&P500 52-week change 321.08%
52-week high 381.40
52-week low 357.97
50-day moving average 361.10
200-day moving average 366.81

Share statistics

Avg vol (3-month) 3354.44k
Avg vol (10-day) 3691.26k
Shares outstanding 51.63B
Implied shares outstanding 6N/A
Float 82.02B
% held by insiders 10.10%
% held by institutions 178.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.31
Trailing annual dividend yield 33.19%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -13.50%
Operating margin (ttm)12.76%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)45.53B
Revenue per share (ttm)22.21
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
EBITDA 17.5B
Net income avi to common (ttm)-6.15B
Diluted EPS (ttm)2.82
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)140.82%
Current ratio (mrq)N/A
Book value per share (mrq)14.56

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A